Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin

Andres M.Arias Lorza, Harshan Ravi, Rohit C. Philip, Jean Philippe Galons, Theodore P. Trouard, Nestor A. Parra, Daniel D. Von Hoff, William L. Read, Raoul Tibes, Ronald L. Korn, Natarajan Raghunand

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin'. Together they form a unique fingerprint.

Medicine & Life Sciences